| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pelvic Floor | 8 | 2021 | 138 | 2.490 |
Why?
|
| Uterine Prolapse | 23 | 2008 | 68 | 2.410 |
Why?
|
| Tuberculosis, Meningeal | 11 | 2021 | 49 | 1.430 |
Why?
|
| Gynecologic Surgical Procedures | 14 | 2020 | 287 | 1.300 |
Why?
|
| Urinary Incontinence, Stress | 16 | 2009 | 180 | 1.230 |
Why?
|
| Urinary Incontinence | 9 | 2018 | 490 | 1.130 |
Why?
|
| Pelvic Organ Prolapse | 6 | 2020 | 116 | 0.880 |
Why?
|
| Aneurysm, False | 3 | 2018 | 263 | 0.880 |
Why?
|
| Surgical Mesh | 5 | 2012 | 315 | 0.770 |
Why?
|
| Rectocele | 8 | 2008 | 21 | 0.750 |
Why?
|
| Urogenital Surgical Procedures | 7 | 2007 | 34 | 0.710 |
Why?
|
| Exercise Therapy | 2 | 2018 | 939 | 0.700 |
Why?
|
| Menkes Kinky Hair Syndrome | 1 | 2018 | 18 | 0.620 |
Why?
|
| Blood Preservation | 1 | 2018 | 169 | 0.590 |
Why?
|
| Conversion Disorder | 1 | 2021 | 201 | 0.580 |
Why?
|
| Leprosy, Borderline | 1 | 2016 | 4 | 0.560 |
Why?
|
| Fecal Incontinence | 2 | 2018 | 246 | 0.550 |
Why?
|
| Vagina | 11 | 2016 | 849 | 0.550 |
Why?
|
| Laparoscopy | 11 | 2020 | 2037 | 0.540 |
Why?
|
| Obstetric Labor Complications | 1 | 2018 | 240 | 0.530 |
Why?
|
| Single-Chain Antibodies | 4 | 2022 | 114 | 0.520 |
Why?
|
| Cerebral Palsy | 1 | 2021 | 480 | 0.520 |
Why?
|
| Hypersplenism | 1 | 2015 | 4 | 0.500 |
Why?
|
| Abscess | 2 | 2016 | 606 | 0.500 |
Why?
|
| Hysterectomy, Vaginal | 2 | 2005 | 28 | 0.490 |
Why?
|
| Splenic Artery | 1 | 2015 | 58 | 0.480 |
Why?
|
| Postpartum Hemorrhage | 1 | 2018 | 275 | 0.480 |
Why?
|
| Lipid Bilayers | 2 | 2006 | 377 | 0.460 |
Why?
|
| Skin Transplantation | 4 | 2008 | 1097 | 0.460 |
Why?
|
| Microarray Analysis | 2 | 2007 | 751 | 0.440 |
Why?
|
| Erythrocyte Transfusion | 1 | 2018 | 575 | 0.440 |
Why?
|
| LEOPARD Syndrome | 1 | 2013 | 12 | 0.430 |
Why?
|
| Urinary Bladder Diseases | 5 | 2006 | 166 | 0.420 |
Why?
|
| Blood Transfusion | 2 | 2018 | 1308 | 0.410 |
Why?
|
| Antibodies | 2 | 2020 | 2419 | 0.410 |
Why?
|
| Rectovaginal Fistula | 2 | 2004 | 12 | 0.400 |
Why?
|
| Antibodies, Bispecific | 4 | 2019 | 204 | 0.390 |
Why?
|
| Subacute Sclerosing Panencephalitis | 1 | 2011 | 26 | 0.380 |
Why?
|
| Receptor, erbB-3 | 4 | 2013 | 142 | 0.370 |
Why?
|
| Nanostructures | 2 | 2007 | 549 | 0.360 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2013 | 262 | 0.360 |
Why?
|
| Polymers | 3 | 2007 | 1624 | 0.360 |
Why?
|
| Medical Receptionists | 1 | 2010 | 2 | 0.360 |
Why?
|
| Antibodies, Monoclonal | 8 | 2019 | 9245 | 0.360 |
Why?
|
| Stomach Volvulus | 1 | 2010 | 6 | 0.350 |
Why?
|
| Diaphragmatic Eventration | 1 | 2010 | 4 | 0.350 |
Why?
|
| Biosensing Techniques | 3 | 2007 | 641 | 0.350 |
Why?
|
| Pneumonia, Pneumococcal | 2 | 2022 | 133 | 0.350 |
Why?
|
| Aneurysm, Ruptured | 1 | 2015 | 455 | 0.340 |
Why?
|
| Marketing of Health Services | 1 | 2010 | 151 | 0.320 |
Why?
|
| Embolization, Therapeutic | 2 | 2018 | 1403 | 0.320 |
Why?
|
| Immunoconjugates | 3 | 2024 | 975 | 0.320 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2010 | 112 | 0.310 |
Why?
|
| Tic Disorders | 1 | 2010 | 140 | 0.310 |
Why?
|
| Prosthesis Implantation | 2 | 2012 | 594 | 0.310 |
Why?
|
| Practice Management, Medical | 1 | 2010 | 191 | 0.310 |
Why?
|
| Dendrimers | 2 | 2007 | 72 | 0.300 |
Why?
|
| Enzymes, Immobilized | 2 | 2007 | 53 | 0.300 |
Why?
|
| Trigeminal Nerve | 1 | 2010 | 248 | 0.300 |
Why?
|
| Community-Acquired Infections | 2 | 2022 | 470 | 0.280 |
Why?
|
| Nylons | 1 | 2007 | 47 | 0.280 |
Why?
|
| Facial Nerve | 1 | 2010 | 277 | 0.280 |
Why?
|
| Urodynamics | 6 | 2009 | 349 | 0.280 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2007 | 99 | 0.280 |
Why?
|
| Nanocomposites | 1 | 2007 | 55 | 0.280 |
Why?
|
| Telephone | 1 | 2010 | 629 | 0.270 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2024 | 3608 | 0.270 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2007 | 142 | 0.270 |
Why?
|
| Nanoparticles | 4 | 2022 | 1966 | 0.270 |
Why?
|
| Albendazole | 3 | 2020 | 51 | 0.270 |
Why?
|
| Gold | 2 | 2007 | 482 | 0.260 |
Why?
|
| Electronics | 2 | 2007 | 316 | 0.260 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 1660 | 0.260 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 2018 | 198 | 0.260 |
Why?
|
| India | 10 | 2021 | 2334 | 0.250 |
Why?
|
| Sutures | 2 | 1998 | 283 | 0.250 |
Why?
|
| Brain Stem | 1 | 2011 | 858 | 0.250 |
Why?
|
| Electrolytes | 1 | 2006 | 279 | 0.250 |
Why?
|
| Vaginal Diseases | 3 | 2002 | 103 | 0.240 |
Why?
|
| Aorta | 1 | 2013 | 2045 | 0.240 |
Why?
|
| Neurocysticercosis | 2 | 2020 | 91 | 0.230 |
Why?
|
| Humans | 116 | 2024 | 767040 | 0.230 |
Why?
|
| Maleimides | 1 | 2024 | 112 | 0.230 |
Why?
|
| Liposomes | 2 | 2019 | 787 | 0.230 |
Why?
|
| Urination Disorders | 2 | 2002 | 236 | 0.230 |
Why?
|
| Hysteroscopy | 1 | 2004 | 62 | 0.230 |
Why?
|
| Female | 90 | 2024 | 396660 | 0.220 |
Why?
|
| Tuberculoma | 5 | 2016 | 13 | 0.210 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 15925 | 0.210 |
Why?
|
| Radiography, Thoracic | 3 | 2018 | 1320 | 0.210 |
Why?
|
| Phospholipids | 1 | 2006 | 778 | 0.210 |
Why?
|
| Membranes | 1 | 2022 | 164 | 0.200 |
Why?
|
| BCG Vaccine | 1 | 2005 | 381 | 0.200 |
Why?
|
| Electromyography | 2 | 2018 | 1398 | 0.200 |
Why?
|
| Adsorption | 2 | 2017 | 198 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2021 | 36582 | 0.200 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2017 | 1531 | 0.200 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2007 | 1331 | 0.200 |
Why?
|
| Receptor, EphA2 | 2 | 2019 | 41 | 0.190 |
Why?
|
| Spinal Nerve Roots | 1 | 2002 | 122 | 0.190 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2018 | 1429 | 0.190 |
Why?
|
| Amnion | 1 | 2022 | 204 | 0.190 |
Why?
|
| Durapatite | 1 | 2022 | 167 | 0.190 |
Why?
|
| Pelvis | 2 | 2003 | 736 | 0.180 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2013 | 384 | 0.180 |
Why?
|
| Tissue Transplantation | 1 | 2001 | 128 | 0.180 |
Why?
|
| Protein Engineering | 3 | 2016 | 554 | 0.180 |
Why?
|
| Hematoma | 1 | 2005 | 766 | 0.180 |
Why?
|
| Cysticercus | 1 | 2020 | 2 | 0.180 |
Why?
|
| Cicatrix | 2 | 2022 | 798 | 0.180 |
Why?
|
| Heart Ventricles | 1 | 2013 | 3837 | 0.180 |
Why?
|
| Anthelmintics | 2 | 2020 | 83 | 0.170 |
Why?
|
| Treatment Outcome | 22 | 2020 | 65295 | 0.170 |
Why?
|
| Oligopeptides | 1 | 2024 | 1195 | 0.160 |
Why?
|
| Hospitals, University | 2 | 2014 | 570 | 0.160 |
Why?
|
| Pelvic Pain | 1 | 2021 | 300 | 0.160 |
Why?
|
| Diagnostic Techniques, Urological | 1 | 1998 | 27 | 0.160 |
Why?
|
| Hematocrit | 1 | 2000 | 622 | 0.160 |
Why?
|
| Gelatin Sponge, Absorbable | 1 | 2018 | 56 | 0.150 |
Why?
|
| Enbucrilate | 1 | 2018 | 29 | 0.150 |
Why?
|
| Protein Stability | 2 | 2017 | 578 | 0.150 |
Why?
|
| Pneumococcal Infections | 1 | 2022 | 529 | 0.150 |
Why?
|
| Hydrocephalus | 2 | 2016 | 766 | 0.150 |
Why?
|
| Suture Techniques | 4 | 2012 | 775 | 0.150 |
Why?
|
| Antitubercular Agents | 4 | 2020 | 1380 | 0.150 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2019 | 268 | 0.140 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2019 | 347 | 0.140 |
Why?
|
| Phlebography | 1 | 2018 | 326 | 0.140 |
Why?
|
| Ephrin-A2 | 1 | 2016 | 25 | 0.140 |
Why?
|
| Prospective Studies | 18 | 2022 | 54886 | 0.140 |
Why?
|
| Cerebral Veins | 1 | 2018 | 157 | 0.140 |
Why?
|
| Pneumonia | 2 | 2020 | 2159 | 0.140 |
Why?
|
| Parenting | 1 | 2023 | 708 | 0.140 |
Why?
|
| Arachnoiditis | 1 | 2016 | 9 | 0.140 |
Why?
|
| Abnormalities, Multiple | 2 | 2012 | 1424 | 0.140 |
Why?
|
| Eclampsia | 1 | 2017 | 61 | 0.140 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2017 | 50 | 0.130 |
Why?
|
| Renal Artery | 1 | 2018 | 355 | 0.130 |
Why?
|
| Chromatography, Gel | 1 | 2017 | 634 | 0.130 |
Why?
|
| Osteosclerosis | 1 | 1996 | 41 | 0.130 |
Why?
|
| Endometritis | 1 | 1996 | 49 | 0.130 |
Why?
|
| Electric Stimulation Therapy | 1 | 2002 | 635 | 0.130 |
Why?
|
| Africa South of the Sahara | 1 | 2018 | 751 | 0.130 |
Why?
|
| Biofeedback, Psychology | 1 | 2016 | 117 | 0.130 |
Why?
|
| Cyanosis | 2 | 2013 | 82 | 0.130 |
Why?
|
| Copper | 1 | 2018 | 365 | 0.130 |
Why?
|
| Middle Aged | 46 | 2021 | 223233 | 0.130 |
Why?
|
| Thorax | 1 | 2018 | 556 | 0.130 |
Why?
|
| Hemostatics | 1 | 2018 | 247 | 0.120 |
Why?
|
| Adult | 39 | 2021 | 223317 | 0.120 |
Why?
|
| Prostheses and Implants | 1 | 2002 | 1275 | 0.120 |
Why?
|
| Bone Diseases, Developmental | 1 | 1996 | 132 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2019 | 563 | 0.120 |
Why?
|
| Child, Preschool | 14 | 2021 | 42606 | 0.120 |
Why?
|
| Antibody Specificity | 1 | 2017 | 1062 | 0.120 |
Why?
|
| Infant | 12 | 2021 | 36485 | 0.120 |
Why?
|
| Pain | 1 | 2010 | 5101 | 0.120 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2016 | 265 | 0.120 |
Why?
|
| Mice, SCID | 5 | 2020 | 2626 | 0.120 |
Why?
|
| Drug Delivery Systems | 2 | 2016 | 2212 | 0.120 |
Why?
|
| Cytotoxins | 1 | 2015 | 154 | 0.110 |
Why?
|
| Male | 35 | 2021 | 364203 | 0.110 |
Why?
|
| Surgical Flaps | 1 | 2003 | 1680 | 0.110 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 1228 | 0.110 |
Why?
|
| Leprosy, Tuberculoid | 1 | 2013 | 15 | 0.110 |
Why?
|
| Neuritis | 1 | 2013 | 35 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 12 | 2018 | 20741 | 0.110 |
Why?
|
| Fatal Outcome | 1 | 2018 | 1836 | 0.110 |
Why?
|
| Software | 2 | 2018 | 4472 | 0.110 |
Why?
|
| Vaccination | 1 | 2005 | 3434 | 0.110 |
Why?
|
| Surgery Department, Hospital | 1 | 2014 | 170 | 0.110 |
Why?
|
| Adolescent | 22 | 2021 | 89046 | 0.100 |
Why?
|
| Leprosy | 1 | 2013 | 125 | 0.100 |
Why?
|
| Urologic Surgical Procedures | 2 | 2009 | 281 | 0.100 |
Why?
|
| Spinal Diseases | 1 | 2017 | 561 | 0.100 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2021 | 2028 | 0.100 |
Why?
|
| Vascular Fistula | 1 | 2012 | 50 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2015 | 2478 | 0.100 |
Why?
|
| Suburethral Slings | 1 | 2012 | 69 | 0.100 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2018 | 836 | 0.100 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2013 | 164 | 0.100 |
Why?
|
| Arterio-Arterial Fistula | 1 | 2011 | 20 | 0.090 |
Why?
|
| Syndrome | 2 | 2015 | 3271 | 0.090 |
Why?
|
| World Health Organization | 1 | 2017 | 1327 | 0.090 |
Why?
|
| Oral Health | 1 | 2016 | 493 | 0.090 |
Why?
|
| Cell Line, Tumor | 8 | 2024 | 17097 | 0.090 |
Why?
|
| Neuregulin-1 | 1 | 2012 | 136 | 0.090 |
Why?
|
| Pineal Gland | 1 | 1992 | 158 | 0.090 |
Why?
|
| Spinal Neoplasms | 1 | 2017 | 714 | 0.090 |
Why?
|
| Pain Measurement | 1 | 2021 | 3584 | 0.090 |
Why?
|
| Health Literacy | 1 | 2016 | 466 | 0.090 |
Why?
|
| Device Approval | 1 | 2012 | 164 | 0.090 |
Why?
|
| Aged | 30 | 2021 | 171319 | 0.090 |
Why?
|
| Drug Design | 2 | 2013 | 1045 | 0.090 |
Why?
|
| Child | 20 | 2023 | 80771 | 0.090 |
Why?
|
| Anticestodal Agents | 1 | 2010 | 3 | 0.090 |
Why?
|
| Recombinant Proteins | 3 | 2015 | 6507 | 0.090 |
Why?
|
| Situs Inversus | 1 | 2010 | 63 | 0.090 |
Why?
|
| Patient Satisfaction | 3 | 2016 | 3488 | 0.090 |
Why?
|
| Renal Insufficiency | 1 | 2016 | 812 | 0.090 |
Why?
|
| Prenatal Diagnosis | 1 | 2017 | 1271 | 0.080 |
Why?
|
| Home Care Services | 1 | 2016 | 659 | 0.080 |
Why?
|
| Vaccines, Conjugate | 2 | 2022 | 334 | 0.080 |
Why?
|
| Proteins | 1 | 2004 | 6001 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 2 | 2007 | 2628 | 0.080 |
Why?
|
| Ligaments | 3 | 2005 | 127 | 0.080 |
Why?
|
| Parents | 1 | 2023 | 3594 | 0.080 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2012 | 337 | 0.080 |
Why?
|
| Urinary Tract | 3 | 2001 | 305 | 0.080 |
Why?
|
| Equipment Design | 1 | 2016 | 3489 | 0.080 |
Why?
|
| Vestibular Diseases | 1 | 2011 | 232 | 0.080 |
Why?
|
| Hysterectomy | 3 | 2000 | 863 | 0.080 |
Why?
|
| Colpotomy | 1 | 2008 | 9 | 0.080 |
Why?
|
| Pancreatitis | 1 | 2015 | 1087 | 0.070 |
Why?
|
| Evidence-Based Medicine | 2 | 2018 | 3700 | 0.070 |
Why?
|
| Granuloma | 1 | 2010 | 329 | 0.070 |
Why?
|
| Inservice Training | 1 | 2010 | 374 | 0.070 |
Why?
|
| Thermoanaerobacter | 1 | 2007 | 1 | 0.070 |
Why?
|
| L-Iditol 2-Dehydrogenase | 1 | 2007 | 3 | 0.070 |
Why?
|
| Valerates | 1 | 2007 | 20 | 0.070 |
Why?
|
| Butyrylcholinesterase | 1 | 2007 | 21 | 0.070 |
Why?
|
| Conductometry | 1 | 2007 | 10 | 0.070 |
Why?
|
| Robotics | 1 | 2014 | 807 | 0.070 |
Why?
|
| Phenylacetates | 1 | 2007 | 112 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 3738 | 0.070 |
Why?
|
| Tuberculosis | 1 | 2020 | 2011 | 0.070 |
Why?
|
| Acetylcholinesterase | 1 | 2007 | 151 | 0.070 |
Why?
|
| Psychometrics | 1 | 2016 | 3060 | 0.070 |
Why?
|
| Cystocele | 1 | 2006 | 4 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2013 | 2883 | 0.070 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2007 | 113 | 0.070 |
Why?
|
| Cell Proliferation | 4 | 2019 | 10455 | 0.070 |
Why?
|
| Electrochemistry | 1 | 2006 | 144 | 0.070 |
Why?
|
| Colloids | 1 | 2006 | 125 | 0.070 |
Why?
|
| Polyamines | 1 | 2007 | 132 | 0.070 |
Why?
|
| Quartz | 1 | 2006 | 23 | 0.070 |
Why?
|
| Mice, Inbred NOD | 3 | 2019 | 1837 | 0.070 |
Why?
|
| Diagnosis, Differential | 5 | 2017 | 12986 | 0.070 |
Why?
|
| Angiography | 1 | 2012 | 1597 | 0.070 |
Why?
|
| Pneumococcal Vaccines | 2 | 2022 | 414 | 0.070 |
Why?
|
| Lung Transplantation | 1 | 2016 | 1310 | 0.070 |
Why?
|
| Appointments and Schedules | 1 | 2010 | 443 | 0.070 |
Why?
|
| Prosthesis Failure | 1 | 2011 | 1208 | 0.070 |
Why?
|
| Antigens | 1 | 2012 | 1442 | 0.070 |
Why?
|
| Models, Structural | 1 | 2006 | 339 | 0.060 |
Why?
|
| Solutions | 1 | 2006 | 405 | 0.060 |
Why?
|
| Cohort Studies | 4 | 2021 | 41718 | 0.060 |
Why?
|
| Postoperative Complications | 8 | 2020 | 15824 | 0.060 |
Why?
|
| Follow-Up Studies | 10 | 2020 | 39317 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 4648 | 0.060 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2811 | 0.060 |
Why?
|
| Pyrazinamide | 1 | 2005 | 60 | 0.060 |
Why?
|
| Young Adult | 11 | 2021 | 59980 | 0.060 |
Why?
|
| Signal Transduction | 4 | 2019 | 23621 | 0.060 |
Why?
|
| Molecular Conformation | 1 | 2006 | 540 | 0.060 |
Why?
|
| Anemia | 1 | 2015 | 1514 | 0.060 |
Why?
|
| Private Practice | 1 | 2006 | 154 | 0.060 |
Why?
|
| Microchemistry | 1 | 2004 | 54 | 0.060 |
Why?
|
| Heart Atria | 1 | 2011 | 1362 | 0.060 |
Why?
|
| Positron-Emission Tomography | 1 | 2021 | 6550 | 0.060 |
Why?
|
| Catalytic Domain | 1 | 2007 | 699 | 0.060 |
Why?
|
| Dyspnea | 1 | 2013 | 1352 | 0.060 |
Why?
|
| Electrodes | 1 | 2007 | 612 | 0.060 |
Why?
|
| Hernia | 2 | 2002 | 67 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2006 | 939 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 3370 | 0.060 |
Why?
|
| Respiration | 1 | 2011 | 1655 | 0.060 |
Why?
|
| Acute Disease | 1 | 2015 | 7236 | 0.060 |
Why?
|
| Injections, Intramuscular | 1 | 2005 | 551 | 0.060 |
Why?
|
| Alcoholism | 1 | 2015 | 1980 | 0.060 |
Why?
|
| Animals | 15 | 2024 | 168965 | 0.060 |
Why?
|
| Isoniazid | 1 | 2005 | 279 | 0.060 |
Why?
|
| Pregnancy | 5 | 2018 | 30238 | 0.050 |
Why?
|
| Social Behavior | 1 | 2010 | 1147 | 0.050 |
Why?
|
| Neoplasms | 5 | 2020 | 22350 | 0.050 |
Why?
|
| Rifampin | 1 | 2005 | 350 | 0.050 |
Why?
|
| Warfarin | 1 | 2012 | 1493 | 0.050 |
Why?
|
| Transplantation, Homologous | 3 | 2002 | 4838 | 0.050 |
Why?
|
| Calcinosis | 1 | 1992 | 1481 | 0.050 |
Why?
|
| Taxoids | 2 | 2019 | 665 | 0.050 |
Why?
|
| Child Rearing | 1 | 2023 | 74 | 0.050 |
Why?
|
| Valine | 1 | 2024 | 410 | 0.050 |
Why?
|
| Retrospective Studies | 15 | 2020 | 81659 | 0.050 |
Why?
|
| Surgical Procedures, Operative | 1 | 2014 | 1931 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2004 | 277 | 0.050 |
Why?
|
| Macaca fascicularis | 1 | 2024 | 908 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 2815 | 0.050 |
Why?
|
| Sensitivity and Specificity | 5 | 2018 | 14672 | 0.050 |
Why?
|
| Fluorescence | 1 | 2004 | 751 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2015 | 5022 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2006 | 1882 | 0.050 |
Why?
|
| Developmental Disabilities | 1 | 2010 | 1518 | 0.050 |
Why?
|
| Surface Properties | 1 | 2004 | 1154 | 0.050 |
Why?
|
| Dyspareunia | 1 | 2002 | 48 | 0.050 |
Why?
|
| Vasospasm, Intracranial | 1 | 2004 | 207 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2012 | 5891 | 0.050 |
Why?
|
| Receptor, erbB-2 | 1 | 2012 | 2599 | 0.050 |
Why?
|
| Cell Line | 1 | 2015 | 15567 | 0.040 |
Why?
|
| Urination | 1 | 2002 | 204 | 0.040 |
Why?
|
| Organ Preservation | 1 | 2004 | 400 | 0.040 |
Why?
|
| Tumor Burden | 2 | 2019 | 1903 | 0.040 |
Why?
|
| Transplantation, Heterologous | 2 | 2009 | 2391 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7435 | 0.040 |
Why?
|
| Dermis | 1 | 2002 | 203 | 0.040 |
Why?
|
| Prolapse | 1 | 2000 | 63 | 0.040 |
Why?
|
| Uterus | 1 | 2004 | 661 | 0.040 |
Why?
|
| Sacrum | 1 | 2002 | 274 | 0.040 |
Why?
|
| Genital Diseases, Female | 1 | 2001 | 192 | 0.040 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2022 | 446 | 0.040 |
Why?
|
| Incidence | 6 | 2016 | 21526 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2005 | 1110 | 0.040 |
Why?
|
| Digoxin | 1 | 1981 | 246 | 0.040 |
Why?
|
| Disulfides | 1 | 2022 | 462 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2010 | 2780 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2013 | 6000 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2012 | 2817 | 0.040 |
Why?
|
| Meningoencephalitis | 1 | 1999 | 82 | 0.040 |
Why?
|
| Mice | 7 | 2024 | 81912 | 0.040 |
Why?
|
| Seizures | 3 | 2020 | 2996 | 0.040 |
Why?
|
| Abdomen | 2 | 2009 | 1138 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2013 | 3530 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2020 | 828 | 0.040 |
Why?
|
| Echinococcosis, Pulmonary | 1 | 1998 | 7 | 0.040 |
Why?
|
| Postoperative Period | 2 | 2001 | 1824 | 0.040 |
Why?
|
| Aged, 80 and over | 11 | 2018 | 59548 | 0.040 |
Why?
|
| Recurrence | 6 | 2002 | 8504 | 0.040 |
Why?
|
| Wounds, Penetrating | 1 | 2000 | 316 | 0.040 |
Why?
|
| Parent-Child Relations | 1 | 2023 | 772 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2012 | 6260 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 13650 | 0.040 |
Why?
|
| Developing Countries | 1 | 2010 | 2911 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 2337 | 0.040 |
Why?
|
| Fundus Oculi | 1 | 1999 | 560 | 0.040 |
Why?
|
| Materials Testing | 1 | 2001 | 870 | 0.040 |
Why?
|
| Brain Diseases | 3 | 1992 | 1551 | 0.040 |
Why?
|
| Electrodes, Implanted | 1 | 2002 | 835 | 0.040 |
Why?
|
| Videotape Recording | 1 | 1998 | 334 | 0.030 |
Why?
|
| Thoracic Diseases | 1 | 1998 | 99 | 0.030 |
Why?
|
| Epitopes | 2 | 2015 | 2526 | 0.030 |
Why?
|
| Rectum | 1 | 2002 | 898 | 0.030 |
Why?
|
| Cystoscopy | 1 | 1997 | 128 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2006 | 5388 | 0.030 |
Why?
|
| Pelvic Bones | 1 | 1999 | 274 | 0.030 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2002 | 584 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2013 | 3618 | 0.030 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2004 | 1023 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2012 | 4854 | 0.030 |
Why?
|
| Minnesota | 1 | 2016 | 339 | 0.030 |
Why?
|
| Suppuration | 1 | 1996 | 60 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2020 | 702 | 0.030 |
Why?
|
| Anticonvulsants | 2 | 2020 | 1921 | 0.030 |
Why?
|
| Puerperal Disorders | 1 | 1999 | 304 | 0.030 |
Why?
|
| Drug Therapy, Combination | 2 | 2020 | 6310 | 0.030 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2016 | 419 | 0.030 |
Why?
|
| Optic Atrophy | 1 | 1996 | 79 | 0.030 |
Why?
|
| Ligands | 2 | 2015 | 3273 | 0.030 |
Why?
|
| Hospital Charges | 1 | 1997 | 345 | 0.030 |
Why?
|
| Decision Trees | 1 | 2017 | 508 | 0.030 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 1996 | 72 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2011 | 6282 | 0.030 |
Why?
|
| Epilepsy, Generalized | 1 | 1997 | 181 | 0.030 |
Why?
|
| Intraoperative Complications | 2 | 2003 | 1171 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2019 | 2275 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2007 | 5141 | 0.030 |
Why?
|
| Meningitis | 1 | 1996 | 219 | 0.030 |
Why?
|
| Protein Binding | 3 | 2012 | 9327 | 0.030 |
Why?
|
| Swine | 1 | 2004 | 5987 | 0.030 |
Why?
|
| Cadaver | 1 | 1999 | 1362 | 0.030 |
Why?
|
| Radiographic Image Enhancement | 1 | 2018 | 877 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 3834 | 0.030 |
Why?
|
| Reoperation | 3 | 2002 | 4325 | 0.030 |
Why?
|
| Needles | 1 | 1996 | 461 | 0.030 |
Why?
|
| Antibodies, Neoplasm | 1 | 2015 | 282 | 0.030 |
Why?
|
| Brain | 6 | 2020 | 27163 | 0.030 |
Why?
|
| Predictive Value of Tests | 3 | 2013 | 15424 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2004 | 24299 | 0.030 |
Why?
|
| Gynecology | 1 | 1998 | 534 | 0.030 |
Why?
|
| Outpatients | 1 | 2020 | 1600 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2023 | 8732 | 0.030 |
Why?
|
| Encephalitis, Japanese | 1 | 1992 | 13 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2008 | 3414 | 0.020 |
Why?
|
| Cranial Nerve Diseases | 1 | 2013 | 111 | 0.020 |
Why?
|
| Tacrolimus | 1 | 2016 | 751 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 2 | 2015 | 2824 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2006 | 2971 | 0.020 |
Why?
|
| Headache | 1 | 2020 | 1261 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 1997 | 1666 | 0.020 |
Why?
|
| Deafness | 1 | 1996 | 460 | 0.020 |
Why?
|
| Length of Stay | 2 | 2007 | 6489 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2000 | 2252 | 0.020 |
Why?
|
| Collagen | 1 | 2000 | 2636 | 0.020 |
Why?
|
| Binding Sites, Antibody | 1 | 2012 | 340 | 0.020 |
Why?
|
| ROC Curve | 1 | 1999 | 3618 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2001 | 2387 | 0.020 |
Why?
|
| Age Distribution | 2 | 2007 | 2870 | 0.020 |
Why?
|
| Papilledema | 1 | 2013 | 130 | 0.020 |
Why?
|
| Skull | 1 | 1996 | 819 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2021 | 2702 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2011 | 6573 | 0.020 |
Why?
|
| Thoracic Vertebrae | 1 | 1996 | 613 | 0.020 |
Why?
|
| Cricetulus | 1 | 2013 | 810 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1981 | 2257 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2012 | 464 | 0.020 |
Why?
|
| Antibody Affinity | 1 | 2012 | 251 | 0.020 |
Why?
|
| Teaching | 1 | 1998 | 1172 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 1883 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2023 | 3207 | 0.020 |
Why?
|
| Inhalation | 1 | 2011 | 143 | 0.020 |
Why?
|
| Infant, Newborn | 4 | 2017 | 26396 | 0.020 |
Why?
|
| Ambulances | 1 | 2011 | 94 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 6226 | 0.020 |
Why?
|
| Graft Survival | 1 | 2001 | 3896 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 1743 | 0.020 |
Why?
|
| CHO Cells | 1 | 2013 | 1376 | 0.020 |
Why?
|
| Gene Library | 1 | 2013 | 1065 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2012 | 453 | 0.020 |
Why?
|
| Regression Analysis | 1 | 1999 | 6331 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 18330 | 0.020 |
Why?
|
| Stroke | 1 | 2012 | 9746 | 0.020 |
Why?
|
| Sacrococcygeal Region | 1 | 2009 | 52 | 0.020 |
Why?
|
| Urinary Bladder | 2 | 2009 | 1155 | 0.020 |
Why?
|
| Femur | 1 | 1996 | 1321 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2003 | 2787 | 0.020 |
Why?
|
| Health Surveys | 2 | 2010 | 4056 | 0.020 |
Why?
|
| Hospitals | 1 | 2022 | 3883 | 0.020 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2020 | 1911 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2013 | 886 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 1969 | 0.020 |
Why?
|
| Inpatients | 1 | 2020 | 2563 | 0.020 |
Why?
|
| Radiography | 1 | 2020 | 6975 | 0.020 |
Why?
|
| Prognosis | 3 | 2016 | 29963 | 0.020 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2012 | 2538 | 0.020 |
Why?
|
| Hemoglobins, Abnormal | 1 | 1989 | 119 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2022 | 5345 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 5499 | 0.020 |
Why?
|
| Cervix Uteri | 1 | 2012 | 575 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 1492 | 0.020 |
Why?
|
| Comorbidity | 2 | 2016 | 10582 | 0.020 |
Why?
|
| Hand | 1 | 2013 | 910 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 2535 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 2016 | 20169 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2013 | 940 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2016 | 2227 | 0.020 |
Why?
|
| Coenzymes | 1 | 2007 | 101 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2007 | 218 | 0.020 |
Why?
|
| Polyethyleneimine | 1 | 2007 | 70 | 0.020 |
Why?
|
| Algorithms | 2 | 2010 | 14098 | 0.020 |
Why?
|
| Sirolimus | 1 | 2013 | 1539 | 0.020 |
Why?
|
| Epilepsies, Partial | 1 | 1990 | 431 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2017 | 2972 | 0.020 |
Why?
|
| NADP | 1 | 2007 | 229 | 0.020 |
Why?
|
| United States | 6 | 2011 | 72971 | 0.020 |
Why?
|
| Age Factors | 3 | 2007 | 18401 | 0.020 |
Why?
|
| Automobile Driving | 1 | 2011 | 442 | 0.020 |
Why?
|
| Prevalence | 3 | 2008 | 15851 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 2011 | 718 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 1110 | 0.020 |
Why?
|
| Vision Disorders | 1 | 2013 | 1090 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2008 | 1002 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 2457 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 2061 | 0.010 |
Why?
|
| Quality of Life | 3 | 2003 | 13485 | 0.010 |
Why?
|
| Kinetics | 1 | 2012 | 6287 | 0.010 |
Why?
|
| Genetics, Population | 1 | 1989 | 943 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 3928 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4280 | 0.010 |
Why?
|
| United States Food and Drug Administration | 1 | 2011 | 1672 | 0.010 |
Why?
|
| NAD | 1 | 2007 | 618 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2017 | 5098 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12069 | 0.010 |
Why?
|
| Middle Cerebral Artery | 1 | 2004 | 271 | 0.010 |
Why?
|
| Electric Impedance | 1 | 2007 | 792 | 0.010 |
Why?
|
| Sex Factors | 1 | 2016 | 10622 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 4855 | 0.010 |
Why?
|
| Polypropylenes | 1 | 2002 | 63 | 0.010 |
Why?
|
| HIV Infections | 2 | 2020 | 17542 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 22361 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 1981 | 227 | 0.010 |
Why?
|
| Time Factors | 3 | 2016 | 40154 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2004 | 1374 | 0.010 |
Why?
|
| Retreatment | 1 | 2002 | 598 | 0.010 |
Why?
|
| Echocardiography | 1 | 2012 | 5042 | 0.010 |
Why?
|
| Pelvimetry | 1 | 1999 | 5 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2011 | 4525 | 0.010 |
Why?
|
| Risk Factors | 4 | 2010 | 74886 | 0.010 |
Why?
|
| Disease Progression | 1 | 2016 | 13646 | 0.010 |
Why?
|
| Apoptosis | 1 | 2015 | 9513 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1981 | 1377 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2009 | 8310 | 0.010 |
Why?
|
| Fascia | 1 | 1998 | 143 | 0.010 |
Why?
|
| Audiovisual Aids | 1 | 1998 | 97 | 0.010 |
Why?
|
| Phenotype | 1 | 1996 | 16718 | 0.010 |
Why?
|
| Urethra | 1 | 2000 | 406 | 0.010 |
Why?
|
| Cystoscopes | 1 | 1997 | 4 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2007 | 2594 | 0.010 |
Why?
|
| Data Collection | 1 | 2006 | 3321 | 0.010 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 1999 | 364 | 0.010 |
Why?
|
| Dogs | 1 | 1981 | 3834 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2010 | 12451 | 0.010 |
Why?
|
| Research Design | 1 | 2012 | 6210 | 0.010 |
Why?
|
| Parity | 1 | 1999 | 931 | 0.010 |
Why?
|
| Intestinal Diseases | 1 | 1999 | 505 | 0.010 |
Why?
|
| Medical History Taking | 1 | 1999 | 779 | 0.010 |
Why?
|
| Medical Records | 1 | 1999 | 1409 | 0.010 |
Why?
|
| Survival Rate | 1 | 2007 | 12823 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 11872 | 0.010 |
Why?
|
| Educational Measurement | 1 | 1998 | 1259 | 0.010 |
Why?
|
| Catheterization | 1 | 1997 | 1430 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 1998 | 1540 | 0.010 |
Why?
|
| Cerebral Infarction | 1 | 1996 | 968 | 0.010 |
Why?
|
| Electrophoresis, Cellulose Acetate | 1 | 1989 | 16 | 0.010 |
Why?
|
| Education, Medical, Undergraduate | 1 | 1998 | 1087 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 26325 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 18063 | 0.000 |
Why?
|
| Odds Ratio | 1 | 1997 | 9660 | 0.000 |
Why?
|
| Internship and Residency | 1 | 1998 | 5947 | 0.000 |
Why?
|